课题基金 / 基金详情

Anti-carcinogenic Activity--Nsaids Mediated By New Tgf-b

Anti-carcinogenic Activity--Nsaids Mediated By New Tgf-b
新Tgf-b介导的抗癌活性--Nsaids
批准号:
7161805
负责人:
Thomas Eling
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Thomas Eling的其他基金

相似基金

相关文献

中文摘要
翻译
非甾体抗炎药(NSAID)用于治疗炎症性疾病。最近,NSAIDs已被报道对人类结直肠癌的发展具有化学预防作用。NSAID可抑制考克斯-1和/或考克斯-2活性,从而抑制前列腺素合成。然而,一些报告表明,对结肠癌的化学预防作用可能部分不依赖于前列腺素抑制,可能依赖于基因表达。我们的目标是鉴定和表征受包括选择性考克斯抑制剂在内的考克斯抑制剂调控的基因。在我们首次尝试鉴定考克斯调控基因时,我们使用了基于PCR的方法。用NSAIDs治疗人结肠癌细胞以及乳腺癌和肺癌细胞引起新基因(NAG-1,“NSAIDs激活基因”)的上调,我们将其表征为TGF-β超家族基因的成员。该项目有三个主要目的:1)进一步表征NSAID对NAG-1的表达,并探索促炎剂的潜在下调,2)研究NAG-1基因启动子中的反式作用元件,3)使用细胞培养和动物模型鉴定NAG-1蛋白在凋亡和炎症中的生物学功能。此外,我们还利用微阵列技术鉴定了受考克斯抑制剂调控的基因,并发现了许多被诱导和抑制的基因。例如,考克斯抑制剂改变了ATF 3、TSP-1和层粘连蛋白的表达,并且这些蛋白质具有与NSAID的生物活性相关的生物活性。这些研究可能为NSAID的结肠癌减毒和抗炎活性提供新的见解和机制。
英文摘要
Non-steroidal anti-inflammatory drugs (NSAIDs) are used for the treatment of inflammatory diseases. Recently, NSAIDs have been reported to have chemopreventive effects on the development of human colorectal cancer. NSAIDs can inhibit COX-1 and/or COX-2 activity and thus inhibit prostaglandin synthesis. However, some reports indicate that the chemopreventive effect on colon cancer may, in part, be independent of prostaglandin inhibition could dependent on gene expression. Our goal is to identify and characterize genes that are regulated by Cox inhibitors including selective Cox inhibitors. In our first attempt to identify Cox regulated genes we used a PCR based method. Treatment of human colon cancer cells as well as breast and lung cancer cells with NSAIDs caused the up-regulation of novel gene (NAG-1, "NSAIDs activated gene") that we have characterized as member of the TGF-b superfamily gene. The project has with three primary aims; 1) to further characterize the expression of NAG-1 by NSAIDs and to explore the potential down regulation by pro-inflammatory agents, 2) to investigate the transacting elements in the NAG-1 gene promoter, and 3) to identify biological function(s) of NAG-1 protein in apoptosis and inflammation using cell culture and animal models. In addition, we have also used Microarray technology to identify genes regulated by Cox inhibitors and have found a number of genes that are induced and suppressed. For example the expression ATF3, TSP-1 and laminin are altered by Cox inhibitor and these proteins have biological activities associated with the biological activity of NSAIDs. These studies may provide new insights and mechanisms for the attenuation of colon cancer and anti-inflammatory activity of NSAIDs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MECHANISMS THAT REGULATE ENZYMES THAT METABOLIZE CIS UNSATURATED FATTY ACIDS
MECHANISMS THAT REGULATE ENZYMES THAT METABOLIZE CIS UNSATURATED FATTY ACIDS
EICOSANOID FORMATION IN PULMONARY EPITHELIAL CELLS
Anticarcinogenic Activity Of NSAID Mediated By TGFB GENE
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
  • 批准号:
    31970691
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    张胜萍
  • 依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
  • 批准号:
    31900527
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2019
  • 负责人:
    孙磊
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位: